These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 16536817)

  • 1. Etanercept: effective in the management of hidradenitis suppurativa.
    Cusack C; Buckley C
    Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hidradenitis suppurativa with etanercept injection.
    Adams DR; Yankura JA; Fogelberg AC; Anderson BE
    Arch Dermatol; 2010 May; 146(5):501-4. PubMed ID: 20479297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR; Bos JD
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.
    Giamarellos-Bourboulis EJ; Pelekanou E; Antonopoulou A; Petropoulou H; Baziaka F; Karagianni V; Stavrianeas N; Giamarellou H
    Br J Dermatol; 2008 Mar; 158(3):567-72. PubMed ID: 18076705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
    Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
    Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept.
    Henderson RL
    J Drugs Dermatol; 2006; 5(10):1010-1. PubMed ID: 17373153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis suppurativa responding to treatment with infliximab.
    Lasocki A; Sinclair R; Foley P; Saunders H
    Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept for the treatment of hidradenitis suppurativa.
    Sotiriou E; Apalla Z; Ioannidos D
    Acta Derm Venereol; 2009; 89(1):82-3. PubMed ID: 19197548
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
    Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
    Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puerto Rico psoriasis study group: efficacy and safety of etanercept.
    González-Chavez JR; Berlingeri-Ramos AC; Sánchez Casiano MA
    J Drugs Dermatol; 2005; 4(6):735-9. PubMed ID: 16302559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hidradenitis suppurativa. Response to treatment with infliximab].
    Pedraz J; Daudén E; Pérez-Gala S; Goiriz-Valdés R; Fernández-Peñas P; García-Diez A
    Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept.
    Poulin Y
    J Cutan Med Surg; 2009; 13(4):221-5. PubMed ID: 19706231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.